tiprankstipranks
Celyad (CYAD)
OTHER OTC:CYAD

Celyad (CYAD) Stock Investors

0 Followers
Based on 648,884 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CYAD
On average, investors allocate 0.00% of their portfolios to CYAD
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CYAD

1.0%
Last 7
Days
5.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CYAD, out of 648,884 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CYAD Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$0.70
Based on the activity of 12,146 investors who made their portfolios public
The table shows changes in CYAD in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CYAD Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.63%
-0.17%
+0.10%
48.12B
Healthcare
Syros Pharmaceuticals
3.87%
-0.99%
-4.87%
76.20M
Healthcare
DraftKings
6.02%
-0.14%
+0.76%
19.99B
Technology
Twilio
3.10%
+0.42%
+0.46%
11.05B
Technology
Marvell
5.03%
+5.85%
+4.69%
56.14B
Technology
Nikola
5.38%
-0.74%
-2.12%
409.24M
Energy
Cloudflare
4.02%
+0.15%
+0.96%
20.29B
Technology
General Electric
5.82%
+0.54%
+2.59%
111.88B
Industrials
Barrick Gold
6.30%
-0.07%
+0.69%
29.67B
Basic Materials
Mercadolibre
5.56%
+0.62%
+1.83%
64.38B
Technology
Based on the activity of 648,884 active portfolios
Open your Smart Portfolio

CYAD Investor Analysis

CYAD investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
16.1%
of CYAD holders
are under 35
Average Segment Performance
Average P/E Ratio37.63
Beta4.97
Dividend Yield5.14%
CYAD investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
41.9%
of CYAD holders
are between 35–55
Average Segment Performance
Average P/E Ratio40.55
Beta4.92
Dividend Yield6.17%
CYAD investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
41.9%
of CYAD holders
are over 55
Average Segment Performance
Average P/E Ratio40.40
Beta0.42
Dividend Yield5.67%
Overview of age group and performance of CYAD stock investors
See who invests in CYAD according to age group and performance.

FAQ

How many retail Investors hold CYAD?
<0.1% of TipRanks' retail investors hold CYAD in their portfolios.
    What is CYAD Investor Sentiment?
    CYAD’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CYAD in the last 7 days?
      ▼ 1.0% of TipRanks' retail investors changed their holding of CYAD in the last 7 days.
        What percentage of retail investors changed their holding of CYAD in the last 30 days?
        ▼ 5.3% of TipRanks' retail investors changed their holding of CYAD in the last 30 days.
          What is the average age of retail investors who hold CYAD?
          The average age of CYAD Holders is over 55.
            What other stocks have CYAD investors also bought?
            CYAD Investors also bought MRNA, SYRS, DKNG, TWLO, MRVL, NKLA, NET, GE, GOLD, MELI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ABCAmerisourceBergen
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              BIOBio-Rad Laboratories
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis